MedTrace Logo

The Effect of High Tone Power Therapy on Fatigue and Functional Outcomes in Multiple Sclerosis

NCT04530669 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-07-13

No results posted yet for this study

Summary

To investigate the effect of "High Tone Power Therapy" (HTPT) on fatigue and functional outcomes in multiple sclerosis (MS). BACKGROUND: Fatigue and functional limitations considered serious disorders in patients with multiple sclerosis that lead to impairment of the physical activities and disruption of the quality of life (QOL).

HYPOTHESES:

This study hypothesized that:

High Tone Power Therapy will have a significant beneficial effect on fatigue and functional outcomes in in multiple sclerosis

RESEARCH QUESTION:

Is there a beneficial effect of High Tone Power Therapy on fatigue and functional outcomes in multiple sclerosis?

Conditions

Interventions

DEVICE

High Tone Power Therapy

High Tone Power Therapy (HiTop 191): (For group I). The high tone power therapy through using a device (HiTop 191; gbo Medizintechnik, Rimbach, Germany). The intensity of the electrical stimulation will be adjusted to a pleasant level that did not produce any pain or discomfort.

OTHER

exercise program

physical therapy conventional selected exercise program inform of functional activities of daily living

Sponsors & Collaborators

  • Lama Saad El-Din Mahmoud

    lead OTHER

Principal Investigators

  • Lama S Mahmoud · Cairo University

  • Khalid T Turky, PHD · Ph.D., Assist. prof : Physical Therapy

  • Nevin M Shalaby, PHD · Professor of neurology Department of Neurology , Faculty of Medicine, Cairo University.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2020-10-15
Completion
2020-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04530669 on ClinicalTrials.gov